Health & Nutrition
What obesity drugmakers see next in the market: More pills,...
CNBC spoke to executives from Eli Lilly, Novo Nordisk, Pfizer and other drugmakers...
All About Allulose
Sugar and high fructose corn syrup are the original industrial sweeteners—inexpensive,...
Is Fasting an Effective Treatment for Diabetes?
By losing 15% of their body weight, nearly 90% of those who have had type 2 diabetes...
Thanks for your support, here’s how to connect with us
Thank you for your support of CNBC Cures. To share your story or become involved...
OpenAI acquires health-care technology startup Torch for...
Torch CEO Ilya Abyzov previously co-founded Forward, a direct-to-consumer primary...
OpenAI acquires health-care technology startup Torch for...
Torch CEO Ilya Abyzov previously co-founded Forward, a direct-to-consumer primary...
Making U.S. biotech more competitive with China's could...
China is becoming a leader in biotech innovation. That offers hope to rare disease...
Making U.S. biotech more competitive with China's could...
China is becoming a leader in biotech innovation. That offers hope to rare disease...
Healthy Returns: Novo Nordisk CEO on GLP-1 pricing, and...
Novo Nordisk's CEO spoke about GLP-1 pricing and Pfizer's CEO spoke about the company's...
Novo Nordisk shares rise 8% after Wegovy obesity pill has...
The early data is a boost to the Danish drugmaker's hopes of winning back more market...
